Literature DB >> 24434653

RRM1 maintains centrosomal integrity via CHK1 and CDK1 signaling during replication stress.

Su-Hyeon Kim1, Eun-Ran Park1, Hyun-Yoo Joo1, Yan Nan Shen1, Sung Hee Hong1, Chun Ho Kim2, Rachana Singh1, Kee-Ho Lee3, Hyun-Jin Shin4.   

Abstract

DNA lesion-induced centrosomal abnormalities during the replication phase are relatively unknown. Here, we report that RNAi-mediated depletion of RRM1 induces cell-cycle arrest at the replication phase, along with severe DNA damage and centrosomal amplification. Interestingly, CHK1 depletion synergistically increased RRM1-depletion-induced centrosomal amplification. In response to hydroxyurea, CHK1 was delocalized from the centrosome by RRM1 depletion. Moreover, CDK1, which functions in centrosome separation and is inhibited by CHK1, was found to be essential for RRMI1-depletion-induced centrosomal amplification. Thus, we herein demonstrate that RRM1 preserves chromosomal stability via the CHK1- and CDK1-dependent stabilization of the centrosomal integrity at the replication stage.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Centrosome integrity; DNA damage; RRM1; Replication fork stalling; Tumor suppressor; Tumorigenesis

Mesh:

Substances:

Year:  2014        PMID: 24434653     DOI: 10.1016/j.canlet.2013.12.031

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  9 in total

Review 1.  Centrosomes in the DNA damage response--the hub outside the centre.

Authors:  Lisa I Mullee; Ciaran G Morrison
Journal:  Chromosome Res       Date:  2016-01       Impact factor: 5.239

2.  Gemcitabine sensitivity factors, hENT1 and RRM1 as potential prognostic biomarker for advanced biliary tract cancer.

Authors:  Ting Deng; Hong Pan; Rubing Han; Dingzhi Huang; Hongli Li; Likun Zhou; Xia Wang; Ming Bai; Xiang Li; Rui Liu; Shaohua Ge; Tao Ning; Le Zhang; Yi Ba
Journal:  Int J Clin Exp Med       Date:  2014-12-15

3.  Ribonucleotide Reductase Catalytic Subunit M1 (RRM1) as a Novel Therapeutic Target in Multiple Myeloma.

Authors:  Morihiko Sagawa; Hiroto Ohguchi; Takeshi Harada; Mehmet K Samur; Yu-Tzu Tai; Nikhil C Munshi; Masahiro Kizaki; Teru Hideshima; Kenneth C Anderson
Journal:  Clin Cancer Res       Date:  2017-04-25       Impact factor: 12.531

4.  UNC45A localizes to centrosomes and regulates cancer cell proliferation through ChK1 activation.

Authors:  Yasmeen Jilani; Su Lu; Huang Lei; Larry M Karnitz; Ahmed Chadli
Journal:  Cancer Lett       Date:  2014-11-10       Impact factor: 8.679

5.  MicroRNA-1468-5p inhibits glioma cell proliferation and induces cell cycle arrest by targeting RRM1.

Authors:  Kuan Jiang; Tongle Zhi; Wenhui Xu; Xiupeng Xu; Weining Wu; Tianfu Yu; Er Nie; Xu Zhou; Zhongyuan Bao; Xin Jin; Junxia Zhang; Yingyi Wang; Ning Liu
Journal:  Am J Cancer Res       Date:  2017-04-01       Impact factor: 6.166

Review 6.  Interfering Role of ERα on Adiponectin Action in Breast Cancer.

Authors:  Giuseppina Daniela Naimo; Luca Gelsomino; Stefania Catalano; Loredana Mauro; Sebastiano Andò
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-18       Impact factor: 5.555

7.  Proline-rich protein 11 overexpression is associated with a more aggressive phenotype and poor overall survival in ovarian cancer patients.

Authors:  Yu Zhan; Xueyuan Wu; Gang Zheng; Jingjing Jin; Chaofu Li; Guanzhen Yu; Wenfeng Li
Journal:  World J Surg Oncol       Date:  2020-12-04       Impact factor: 2.754

8.  A Novel DNA Damage Repair-Related Gene Signature for Predicting Glioma Prognosis.

Authors:  Jiaoyang Zhan; Shuang Wu; Xu Zhao; Jingjing Jing
Journal:  Int J Gen Med       Date:  2021-12-21

9.  De novo deoxyribonucleotide biosynthesis regulates cell growth and tumor progression in small-cell lung carcinoma.

Authors:  Ami Maruyama; Yuzo Sato; Joji Nakayama; Junko Murai; Takamasa Ishikawa; Tomoyoshi Soga; Hideki Makinoshima
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.